Ramucirumab (brand name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors. This drug was developed by ImClone...
14 KB (1,302 words) - 07:55, 1 July 2024
(INN) ramnodigin (INN) ramoplanin (INN) ramorelix (INN) ramosetron (INN) ramucirumab (USAN) ranagengliotucel-T (USAN) ranelic acid (INN) ranibizumab (INN)...
5 KB (286 words) - 04:52, 6 September 2024
Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
121 KB (13,799 words) - 17:37, 8 October 2024
(ATTR) Lucinactant (Surfaxin) for infant respiratory distress syndrome Ramucirumab (Cyramza) for gastric and non-small cell lung cancer Dinutuximab (Unituxin)...
24 KB (2,417 words) - 04:42, 24 September 2024
Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
68 KB (5,999 words) - 20:41, 31 August 2024
Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
31 KB (3,430 words) - 05:24, 28 August 2024
the above are treated with second-line chemotherapeutics docetaxel and ramucirumab. Integrating palliative care (medical care focused on improving symptoms...
90 KB (9,784 words) - 19:27, 6 October 2024
Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
13 KB (1,177 words) - 02:19, 4 September 2024
antibodies can be targeted against malignant cells by several mechanisms. Ramucirumab is a recombinant human monoclonal antibody and is used in the treatment...
57 KB (4,072 words) - 11:12, 5 August 2024
Quizartinib Ripretinib Sunitinib Sorafenib Toceranib Antibodies: Olaratumab Ramucirumab Tovetumab RET (GFL) SCF (c-Kit) Agonists: Ancestim Stem cell factor Kinase...
42 KB (3,935 words) - 04:01, 30 April 2024